Department of Medicine, Unit of Nephrology, Dialysis and Renal Transplant, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan,
Department of Medicine, Unit of Nephrology, Dialysis and Renal Transplant, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Blood Purif. 2019;47(1-3):37-44. doi: 10.1159/000492918. Epub 2018 Sep 17.
Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.
继发性甲状旁腺功能亢进症（SHPT）是慢性肾脏病（CKD）患者的常见病症。在 CKD 患者中，SHPT 被报道会增加发病率和死亡率，尤其是心血管疾病的发病率和死亡率。在临床实践中，SHPT 的治疗常常面临困难，这主要是由于临床医生的治疗方法并不总是恰当，以及 CKD 患者普遍不遵守治疗方案。在这篇综述中，我们将从临床医生和 CKD 患者的角度出发，讨论治疗 SHPT 时遇到的最大困难，特别关注与透析特点、营养习惯和药物治疗相关的问题。
